Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019

SELL
$43.37 - $59.54 $234,198 - $321,516
-5,400 Closed
0 $0
Q3 2018

Oct 18, 2018

SELL
$42.88 - $53.7 $38,592 - $48,330
-900 Reduced 14.29%
5,400 $279,000
Q2 2018

Jul 23, 2018

BUY
$40.53 - $50.7 $255,339 - $319,410
6,300 New
6,300 $0

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Mizuho Securities Usa LLC Portfolio

Follow Mizuho Securities Usa LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Usa LLC with notifications on news.